Home https://server7.kproxy.com/servlet/redirect.srv/sruj/smyrwpoii/p2/ Business https://server7.kproxy.com/servlet/redirect.srv/sruj/smyrwpoii/p2/ The FDA has approved an emergency use permit for the COVID-19 drug combination

The FDA has approved an emergency use permit for the COVID-19 drug combination



A sign for the Food and Drug Administration is visible in front of the headquarters on July 20, 2020 in White Oak, Maryland. (Photo: Sarah Silbiger / Getty Images)

TO the editorial office
UPDATED 18:45 PT – Friday, November 20, 2020

The FDA has issued an emergency authorization for a combination of coronavirus drugs to treat moderate to severe patients.

FDA Commissioner Dr. Stephen M. Hahn said the action demonstrates the agency’s continued efforts to provide timely treatment for coronavirus.

On Thursday, the FDA approved the combination of remdesevir and the rheumatoid arthritis drug baricitinib. This happened after studies found that the drug combination shortened the recovery time of COVID-19 to about a week.

According to a double-blind study, the combination also increased the chances of survival by 35% compared with patients taking remdezivir alone.

MORE NEWS: Trump’s campaign: Americans do not trust the mainstream media coverage of the election




Source link